Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthy ExtractsHYEX 53 3-1 Month Momentum % is -19.12% as of Aug. 26, 2026. GuruFocus rates HYEX with a GF Score™ of 53/100 and a GF Value™ of $1.15 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Healthy Extracts ranks worse than 79.22% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-26), Healthy Extracts's 3-1 Month Momentum % is -19.12%.
The industry rank for Healthy Extracts's 3-1 Month Momentum % or its related term are showing as below:
HYEX's 3-1 Month Momentum % is ranked worse than 79.22% of 1020
companies
in the Drug Manufacturers industry
Industry Median: -5.825
vs HYEX: -19.12
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Healthy Extracts 3-1 Month Momentum % Related Terms
HYEX vs CABR, BFRI, IGPK: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts (HYEX) has a 3-1 Month Momentum % of -19.12% as of Aug. 26, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Healthy Extracts and its competitors. According to the industry distribution chart, Healthy Extracts ranks #808 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 79.2%.
Is Healthy Extracts' 3-1 Month Momentum % too high?
Healthy Extracts' current 3-1 Month Momentum % is -19.12%. Based on the distribution chart, Healthy Extracts ranks #808 out of 1020 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Healthy Extracts has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' 3-1 Month Momentum % compare to CABR and BFRI?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #808 out of 1020 companies for 3-1 Month Momentum %. This places Healthy Extracts in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Healthy Extracts and its competitors. Healthy Extracts's current 3-1 Month Momentum % is -19.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Fairly Valued. The stock's GF Value™ is $1.15, compared to a current price of $1.17 — trading 1.7% above its estimated fair value. The current 3-1 Month Momentum % is -19.12%. Healthy Extracts' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current 3-1 Month Momentum % is -19.12% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be overvalued.
The current stock price of $1.17 is trading 1.7% above its estimated GF Value™ of $1.15.
GuruFocus considers Healthy Extracts to be Fairly Valued.
Key valuation signals for HYEX:
3-1 Month Momentum %: -19.12%
GF Value™: $1.15 vs. price of $1.17 (1.7% above fair value)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
53GF Score
Get the complete analysis for HYEX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
